Approximately 5.1 million Israelis had been fully immunized against coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) by May 31, 2021. After early reports of myocarditis during adverse events monitoring, the Israeli Ministry of Health initiated active surveillance.

Matéria original

Anterior

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Próxima

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months